Skip to main content
. 2016 May 13;7(25):37882–37892. doi: 10.18632/oncotarget.9352

Figure 1. Global analysis of Vβ-Jβ gene segment combinations.

Figure 1

(A, B) The frequencies of TCRβ V (A) and J (B) gene segments in peripheral blood samples at baseline (pre) and following 2 cycles of decitabine therapy (post) from UPN1 and UPN2 are shown. (CF) Frequencies of specific Vβ-Jβ gene segment combinations in TCRβ CDR3 sequences are expressed in UPN1 (C), UPN2 (D), UPN3 (E), and UPN4 (F) before and after decitabine therapy.